Efficacy and safety of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: a systematic review and meta-analysis
Michal Sternschuss, Rinat Yerushalmi, Ramy Saleh, Eitan Amir, Hadar Goldvaser
Topics & Concepts
MedicineInternal medicineHazard ratioOdds ratioOncologyTriple-negative breast cancerBreast cancerAdverse effectChemotherapyMeta-analysisConfidence intervalCancerGastroenterologyCancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesImmunotherapy and Immune Responses